- Home
- SPB vs SPRY Comparison
SPB vs SPRY Comparison
Compare SPB & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPB | SPRY |
|---|---|---|
| Founded | 1906 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SPB | SPRY |
|---|---|---|
| Price | $59.78 | $11.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $83.50 | $31.25 |
| AVG Volume (30 Days) | 286.8K | ★ 1.7M |
| Earning Date | 02-05-2026 | 11-10-2025 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.86 | N/A |
| Revenue | ★ $2,809,000,000.00 | $142,772,000.00 |
| Revenue This Year | $1.64 | N/A |
| Revenue Next Year | $1.47 | $127.81 |
| P/E Ratio | $15.54 | ★ N/A |
| Revenue Growth | N/A | ★ 5459.66 |
| 52 Week Low | $49.99 | $6.66 |
| 52 Week High | $87.23 | $18.90 |
Technical Indicators
Market Signals| Indicator | SPB | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 62.92 |
| Support Level | $59.01 | $9.78 |
| Resistance Level | $60.81 | $11.50 |
| Average True Range (ATR) | 1.81 | 0.73 |
| MACD | -0.18 | 0.12 |
| Stochastic Oscillator | 54.39 | 90.17 |
Price Performance
Historical ComparisonAbout SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.